These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 40644)

  • 1. The effects of neuroleptics with central dopamine and noradrenaline receptor blocking properties in the L-DOPA and (+)-amphetamine-induced waking EEG in the rat.
    Monti JM
    Br J Pharmacol; 1979 Sep; 67(1):87-91. PubMed ID: 40644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex.
    Berridge CW; Stalnaker TA
    Synapse; 2002 Dec; 46(3):140-9. PubMed ID: 12325041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oxolinic acid on the sleep-wakefulness cycle of the rat.
    D'Angelo L; Monti JM
    Br J Pharmacol; 1981 Oct; 74(2):399-404. PubMed ID: 7317689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of post-etorphine catalepsy. Modyfying effect of amphetamine, apomorphine and dihydroxy-phenylalanine (L-dopa) on etorphine-induced concentrations of dopamine and noradrenaline in the rat central nervous system.
    Kania BF
    Acta Physiol Pol; 1979; 30(2):279-87. PubMed ID: 572616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of both pilocarpine and amphetamine-induced head-shaking with dopamine receptor antagonists.
    Holmgren B; Urbá-Holmgren R; Dem B
    Pharmacol Biochem Behav; 1978 Jun; 8(6):767-9. PubMed ID: 693563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.
    Janssen PA; Niemegeers CJ; Awouters F; Schellekens KH; Megens AA; Meert TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):685-93. PubMed ID: 2450200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV; Groenewegen HJ; Voorn P
    Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain dopamine and seizure susceptibility in mice.
    Kleinrok Z; Czuczwar S; Wójcik A; Przegaliński E
    Pol J Pharmacol Pharm; 1978; 30(4):513-9. PubMed ID: 740553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
    Groppetti A; Ceresoli G; Mandelli V; Parenti M
    J Pharmacol Exp Ther; 1990 Jun; 253(3):950-6. PubMed ID: 2162953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of some dopaminoceptor agents on nitrazepam-induced sleep in the domestic fowl (Gallus domesticus) and rats.
    Wambebe C
    Jpn J Pharmacol; 1986 Mar; 40(3):357-65. PubMed ID: 3012162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of catecholamine receptor antagonists on ethanol-induced locomotor stimulation.
    Liljequist S; Berggren U; Engel J
    J Neural Transm; 1981; 50(1):57-67. PubMed ID: 6110703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of haloperidol, spiperone and pimozide on the flexor reflex of the hind limb of the spinal rat.
    Maj J; Palider W; Rawłów A
    J Neural Transm; 1978; 43(2):113-20. PubMed ID: 731232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of D-1 dopamine receptors by SCH 23390 prevents EEG and behavioral activation induced by L-dopa.
    Ongini E; Caporali MG; Longo VG
    Neurosci Lett; 1987 Nov; 82(2):206-10. PubMed ID: 2962017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoaminergic mechanisms of stimulation-produced analgesia.
    Akil H; Liebeskind JC
    Brain Res; 1975 Aug; 94(2):279-96. PubMed ID: 125141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of preparations that alter catecholaminergic processes on the serotoninergic syndrome of head twitching in mice].
    Shchelkunov EL
    Farmakol Toksikol; 1979; 42(5):470-4. PubMed ID: 39775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep: effects of d- and l-amphetamine in man and in rat.
    Hartmann E; Cravens J
    Psychopharmacology (Berl); 1976 Nov; 50(2):171-5. PubMed ID: 826958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dopamine supersensitivity on lateral hypothalamic self-stimulation in rats.
    Ettenberg A; Milner PM
    Pharmacol Biochem Behav; 1977 Dec; 7(6):507-14. PubMed ID: 563603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.
    Heal DJ; Green AR; Boullin DJ; Grahame-Smith DG
    Psychopharmacology (Berl); 1976 Sep; 49(3):287-300. PubMed ID: 12527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.